Belgium· BE-AMP-SAM503226-00

Buprenorphine Teva Wekelijks 5 µg/h

A buprenorphine product containing buprenorphine, registered in Belgium by Teva Pharma Belgium. The same ATC class is registered in 13 of our 19 countries.

ATC N02AE01

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about buprenorphineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Buprenorphine is registered in 13 of 19 countries.

Countries holding a registration under ATC N02AE01 (buprenorphine), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search buprenorphine products by name

Buprenorphine · ATC N02AE01

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of buprenorphine costs, country by country.

Normalised to the WHO defined daily dose (1.2 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Buprenorphine · price per daily dose (1.2 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.77

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Buprenorphine
Manufacturer: Teva Pharma Belgium
Country: Belgium (BE)
ATC code: N02AE01
ATC class: Buprenorphine
Defined daily dose: 1.2 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
3632429
be_apb
7721228

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

378 interactions on record for buprenorphine.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check buprenorphine against other medicines How interaction checks work

Buprenorphine · interactions on record

378 records

59 severe
253 moderate
2 minor
52 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
DronabinolA04AD10severe

12 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Buprenorphine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All buprenorphine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Astec, Bupensan
Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
Cyprus · Buvera
Czechia · Addnok, Buprenorfin Stada
Germany · Acimaphin, Acinorphin
Denmark · Buprefarm, Bupremyl
Estonia · Buprenorphine G.L. Pharma
Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
Finland · Buprefarm, Bupremyl
France · Bupensan, Buprenorphine Arrow
United Kingdom (Northern Ireland) · Addnok, Bunov
Greece · Buprenal, Buvera
Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
Ireland · Buprenorphine Activase Pharmaceuticals, Buprenorphine Morningside Healthcare
Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
Italy · Buprenorfina Molteni, Buprenorfina Sandoz
Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
Luxembourg · Temgesic, Temgesic Sublingualis
Latvia · Buprenorphine G.L. Pharma
Malta · Buprenorphine Aspire Pharma (Malta), Natzon
Netherlands · Buprenorfine, Buprenorfine 1a Pharma
Norway · Bugnanto, Buprefarm
Poland · Bunondol, Bunorfin
Portugal · Buprenorfina, Buprenorfina Aurovitas
Sweden · Buprefarm, Buprenorfin Actavis
Slovenia · Addnok, Buprenorfin Alkaloid-Int
Slovakia · Bupretec, Noprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e1d80b25-c10f-4b63-b655-d4ed661a5d15
GET /v1/drugs/e1d80b25-c10f-4b63-b655-d4ed661a5d15?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Transdermal patch",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Buprenorphine Teva Weekly 5 µg/h",
  "name_fr": "Buprenorphine Teva Hebdomadaire 5 µg/h",
  "name_nl": "Buprenorphine Teva Wekelijks 5 µg/h",
  "amp_code": "SAM503226-00",
  "strengths": [
    "5.0000",
    "5.0000"
  ],
  "pack_count": 8,
  "substances": [
    "Buprenorphine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Buprenorphine",
  "authorisation_numbers": [
    "BE503226"
  ]
}

API reference MCP server Plans

See everything about buprenorphine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console